Black Diamond Therapeutics, Inc.
BDTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001701541
No open-market purchases or sales by Black Diamond Therapeutics, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $64.9M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Black Diamond Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- −8 vs. Q4 2022
- Shares held
- 21.5M
- +438.8K (+2.1%) vs. Q4 2022
- Total value
- $40.6M
- +$2.72M (+7.2%) vs. Q4 2022
- New holders
- 1
- 8 more added
- Sold out
- 9
- 17 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 96 | $64.9M |
| Q1 2026 | 104 | $82.0M |
| Q4 2025 | 104 | $92.0M |
| Q3 2025 | 91 | $147.0M |
| Q2 2025 | 94 | $95.8M |
| Q1 2025 | 85 | $63.0M |
| Q4 2024 | 88 | $102.5M |
| Q3 2024 | 96 | $211.9M |
| Q2 2024 | 90 | $217.9M |
| Q1 2024 | 88 | $199.9M |
| Q4 2023 | 76 | $107.1M |
| Q3 2023 | 73 | $106.8M |
| Q2 2023 | 74 | $209.2M |
| Q1 2023 | 50 | $40.6M |
| Q4 2022 | 59 | $37.9M |
| Q3 2022 | 69 | $36.3M |
| Q2 2022 | 74 | $52.9M |
| Q1 2022 | 87 | $63.5M |
| Q4 2021 | 95 | $123.7M |
| Q3 2021 | 101 | $206.3M |
| Q2 2021 | 102 | $309.6M |
| Q1 2021 | 113 | $705.5M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Black Diamond Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 195 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 9 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 17 | $32 | 0.00% | −96−85.0% | Reduced |
| New England Capital Financial Advisors LLC | 24 | $46 | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 35 | $67 | 0.00% | 00.0% | Unchanged |
| Beaird Harris Wealth Management, LLC | 36 | $69 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 84 | $158 | 0.00% | +75+833.3% | Added |
| Federation des caisses Desjardins du Quebec | 280 | $529 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 552 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 641 | $1.21K | 0.00% | +402+168.2% | Added |
| US Bancorp | 700 | $1.32K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 4,002 | $6.84K | 0.00% | +1,220+43.9% | Added |
| Tower Research Capital LLC (TRC) | 7,627 | $15.0K | 0.00% | +4,162+120.1% | Added |
| Cambridge Investment Research Advisors, Inc. | 11,231 | $21.0K | 0.00% | 00.0% | Unchanged |
| K2 Principal Fund, L.P. | 11,316 | $21.4K | 0.01% | −146,876−92.8% | Reduced |
| Bank of America Corp | 12,789 | $24.2K | 0.00% | −25−0.2% | Reduced |
| Federated Hermes, Inc. | 13,185 | $24.9K | 0.00% | −142,034−91.5% | Reduced |
| Bank of New York Mellon Corp | 18,191 | $34.4K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 19,351 | $36.6K | 0.00% | 00.0% | Unchanged |
| State of Wisconsin Investment Board | 20,500 | $38.7K | 0.00% | −20,700−50.2% | Reduced |
| HSBC Holdings PLC | 24,156 | $44.9K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 25,920 | $49.0K | 0.00% | −26,602−50.6% | Reduced |
| Morgan Stanley | 27,974 | $52.9K | 0.00% | −3,228−10.3% | Reduced |
| Beacon Capital Management, LLC | 35,615 | $67.3K | 0.02% | 00.0% | Unchanged |
| AE Wealth Management LLC | 35,920 | $67.9K | 0.00% | −27−0.1% | Reduced |
| Goldman Sachs Group Inc | 36,679 | $69.3K | 0.00% | −327−0.9% | Reduced |
| Northern Trust Corp | 37,983 | $71.8K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 53,365 | $99.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 75,000 | $141.8K | 0.00% | −50,000−40.0% | Reduced |
| State Street Corp | 76,384 | $144.4K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 107,733 | $203.6K | 0.00% | +41,919+63.7% | Added |
| Two Sigma Investments, LP | 107,754 | $203.7K | 0.00% | −35,910−25.0% | Reduced |
| Tekla Capital Management LLC | 131,990 | $249.5K | 0.01% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 144,888 | $273.8K | 0.07% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 175,900 | $332.5K | 0.00% | −36,600−17.2% | Reduced |
| Renaissance Technologies LLC | 217,500 | $411.0K | 0.00% | −3,113−1.4% | Reduced |
| Geode Capital Management, LLC | 270,428 | $511.1K | 0.00% | +5,138+1.9% | Added |
| Newtyn Management, LLC | 306,609 | $579.5K | 0.11% | −8,391−2.7% | Reduced |
| Verition Fund Management LLC | 344,307 | $650.7K | 0.01% | +344,307 | New |
| Citadel Advisors LLC | 557,771 | $1.05M | 0.00% | −216,027−27.9% | Reduced |
| BlackRock Inc. | 756,387 | $1.43M | 0.00% | −237,382−23.9% | Reduced |
| Vanguard Group Inc | 757,585 | $1.43M | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 776,594 | $1.47M | 0.00% | +252,037+48.0% | Added |
| EcoR1 Capital, LLC | 1,191,094 | $2.25M | 0.07% | +908,963+322.2% | Added |
| Artal Group S.A. | 1,646,517 | $3.11M | 0.18% | 00.0% | Unchanged |
| Boxer Capital, LLC | 2,014,858 | $3.81M | 0.19% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 2,589,904 | $4.89M | 0.11% | 00.0% | Unchanged |
| NEA Management Company, LLC | 3,448,757 | $6.52M | 0.45% | 00.0% | Unchanged |
| Bellevue Group AG | 5,395,839 | $10.2M | 0.15% | −5,000−0.1% | Reduced |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −97,500−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −34,400−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −20,212−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −17,295−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,914−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,433−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −1,201−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| Investors Research Corp | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| CoreCap Advisors, LLC | – | – | – | – | Not filed |